Article Versions Notes

Pellegatta S, Corradino N, Zingarelli M, Porto E, Gionso M, Berlendis A, Durando G, Maffezzini M, Musio S, Aquino D, et al. The Immunomodulatory Effects of Fluorescein-Mediated Sonodynamic Treatment Lead to Systemic and Intratumoral Depletion of Myeloid-Derived Suppressor Cells in a Preclinical Malignant Glioma Model. Cancers. 2024; 16(4):792. https://doi.org/10.3390/cancers16040792

Pellegatta, Serena, Nicoletta Corradino, Manuela Zingarelli, Edoardo Porto, Matteo Gionso, Arianna Berlendis, Gianni Durando, Martina Maffezzini, Silvia Musio, Domenico Aquino, and et al. 2024. "The Immunomodulatory Effects of Fluorescein-Mediated Sonodynamic Treatment Lead to Systemic and Intratumoral Depletion of Myeloid-Derived Suppressor Cells in a Preclinical Malignant Glioma Model" Cancers 16, no. 4: 792. https://doi.org/10.3390/cancers16040792

Pellegatta, S., Corradino, N., Zingarelli, M., Porto, E., Gionso, M., Berlendis, A., Durando, G., Maffezzini, M., Musio, S., Aquino, D., DiMeco, F., & Prada, F. (2024). The Immunomodulatory Effects of Fluorescein-Mediated Sonodynamic Treatment Lead to Systemic and Intratumoral Depletion of Myeloid-Derived Suppressor Cells in a Preclinical Malignant Glioma Model. Cancers, 16(4), 792. https://doi.org/10.3390/cancers16040792